Bioinformatically detectable group of novel regulatory genes and uses thereof
First Claim
1. A bioinformatically detectable novel gene encoding substantially pure DNA wherein:
- RNA encoded by said bioinformatically detectable novel gene is about 18 to about 24 nucleotides in length, and originates from an RNA precursor, which RNA precursor is about 50 to about 120 nucleotides in length;
a nucleotide sequence of a first half of said RNA precursor is a partial or accurate inversed reversed sequence of a nucleotide sequence of a second half thereof;
a nucleotide sequence of said RNA encoded by said novel gene is a partial or accurate inversed reversed sequence of a nucleotide sequence of a binding site associated with at least one target gene;
said novel gene cannot be detected by either of the following;
a visually discernable whole body phenotype; and
detection of 99.9% of RNA species shorter than 25 nucleotides expressed in a tissue sample; and
a function of said novel gene is bioinformatically deducible.
3 Assignments
0 Petitions
Accused Products
Abstract
The present invention relates to a first group of novel genes, here identified as genomic address messenger or GAM genes, and a second group of novel operon-like genes, here identified as genomic record or GR genes. GAM genes selectively inhibit translation of known ‘target’ genes, many of which are known to be involved in various diseases. Nucleic acid molecules are provided respectively encoding 8607 GAM genes, and 1096 GR genes, as are vectors and probes both comprising the nucleic acid molecules, and methods and systems for detecting GAM and GR genes and specific functions and utilities thereof, for detecting expression of GAM and GR genes, and for selectively enhancing and selectively inhibiting translation of the respective target genes thereof.
-
Citations
16 Claims
-
1. A bioinformatically detectable novel gene encoding substantially pure DNA wherein:
-
RNA encoded by said bioinformatically detectable novel gene is about 18 to about 24 nucleotides in length, and originates from an RNA precursor, which RNA precursor is about 50 to about 120 nucleotides in length;
a nucleotide sequence of a first half of said RNA precursor is a partial or accurate inversed reversed sequence of a nucleotide sequence of a second half thereof;
a nucleotide sequence of said RNA encoded by said novel gene is a partial or accurate inversed reversed sequence of a nucleotide sequence of a binding site associated with at least one target gene;
said novel gene cannot be detected by either of the following;
a visually discernable whole body phenotype; and
detection of 99.9% of RNA species shorter than 25 nucleotides expressed in a tissue sample; and
a function of said novel gene is bioinformatically deducible. - View Dependent Claims (6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16)
-
-
2. A bioinformatically detectable novel gene encoding substantially pure DNA wherein:
-
RNA encoded by said bioninformatically detectable novel gene comprises a plurality of RNA sections, each of said RNA sections being about 50 to about 120 nucleotides in length, and comprising an RNA segment, which RNA segment is about 18 to about 24 nucleotides in length;
a nucleotide sequence of a first half of each of said RNA sections encoded by said novel gene is a partial or accurate inversed reversed sequence of nucleotide sequence of a second half thereof;
a nucleotide sequence of each of said RNA segments encoded by said novel gene is a partial or accurate inversed reversed sequence of the nucleotide sequence of a binding site associated with at least one target gene; and
a function of said novel gene is bioinformatically deducible from the following data elements;
said nucleotide sequence of said RNA encoded by said novel gene, a nucleotide sequence of said at least one target gene, and function of said at least one target gene.
-
-
3. A bioinformatically detectable novel gene encoding substantially pure DNA wherein:
-
RNA encoded by said bioinformatically detectable novel gene is about 18 to about 24 nucleotides in length, and originates from an RNA precursor, which RNA precursor is about 50 to about 120 nucleotides in length;
a nucleotide sequence of a first half of said RNA precursor is a partial or accurate inversed reversed sequence of a nucleotide sequence of a second half thereof;
a nucleotide sequence of said RNA encoded by said novel gene is a partial or accurate inversed reversed sequence of a nucleotide sequence of a binding site associated with at least one target gene;
a function of said novel gene is modulation of expression of said at least one target gene; and
said at least one target gene does not encode a protein.
-
-
4. A bioinformatically detectable novel gene encoding substantially pure DNA wherein:
-
said bioinformatically detectable novel gene does not encode a protein;
RNA encoded by said bioinformatically detectable novel gene is maternally transferred by a cell to at least one daughter cell of said cell;
a function of said novel gene comprises modulation of a cell type of said daughter cell; and
said modulation is bioinformatically deducible.
-
-
5. A bioinformatically detectable novel gene encoding substantially pure DNA wherein:
-
said bioinformatically detectable novel gene does not encode a protein;
a function of said novel gene is promotion of expression of said at lease one target gene; and
said at least one target gene is bioinformatically deducible.
-
Specification